Clinical Trial Update: The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

View source ↗

Summary

Karolinska Institutet is conducting a study to assess hemorrhagic risk in neonatal thrombocytopenia, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Thrombocytopenia

Snippet

Sponsor: Karolinska Institutet | Conditions: Neonatal Thrombocytopenia, Bleeding | Status: RECRUITING